Recent Blog Posts

View Post: Virology Journal
Full text
Meta-analysis: Adefovir dipivoxil ... ...
View Blog: Currently, there are no conclusive results on the efficacy of adefovir dipivoxil (ADV) plus lamivudine (LAM) in LAM-resistant patients with chronic hepatitis B (CHB). The aim of study was to evaluate the efficacy of rescue therapy with

---

View Post: Gilead and GlaxoSmithKline to commercialize Viread for chronic ...
14 hours ago
The Viread accord modifies the terms of the April 2002 licensing agreement between the two firms under which GSK received exclusive rights to Hepsera (adefovir dipivoxil), Gilead's first hepatitis B treatment, in various territories ...
View Blog: thepharmaletter.com - http://www.thepharmaletter.com/

---

View Post: Gilead Sciences and GlaxoSmithKline enter licensing agreement for ...
25 Nov 2009 by silico  
The Viread agreement modifies the terms of the April 2002 licensing agreement between the two companies which granted GSK exclusive rights to Hepsera(R) (adefovir dipivoxil), Gilead's first hepatitis B treatment, in various territories ...
View Blog: Silico Research - http://silico.wordpress.com/

---

View Post: Gilead and GlaxoSmithKline Announce Agreement to Commercialize ...
23 Nov 2009
The Viread agreement modifies the terms of the April 2002 licensing agreement between Gilead and GSK under which GSK received exclusive rights to Hepsera® (adefovir dipivoxil), Gilead's first hepatitis B treatment, ...
View Blog: Pharma News from PharmiWeb.com - http://www.pharmiweb.com/

---

View Post: Hepatitis B (chronic) - adefovir dipivoxil and pegylated ...
21 Feb 2006
NICE has made the following recommendations about the use of adefovir dipivoxil and peginterferon alfa-2a to treat chronic hepatitis B. These recommendations do not apply to people who are also infected with hepatitis C or D, or HIV. ...
View Blog: NICE

---

View Post: DDW 2009 Reveals Advances Being Made In The Treatment Of Hepatitis
15 Oct 2009 by admin  
Two year follow-up data from this ongoing trial demonstrate that hepatitis B (HBV) patients with persistent viremia (presence of virus of blood) while receiving adefovir dipivoxil (ADV) therapy may be safely and effectively switched to ...
View Blog: Discuss Pharmacy - http://discusspharmacy.com/

---

View Post: Trends in Waiting List Registration for Liver Transplantation
2 Nov 2009 by Scott Weinstein  
Adefovir dipivoxil was approved in 2002, entecavir in 2005, and telbivudine in 2006. In addition, tenofovir disoproxil fumarate, approved for HBV in 2008, had been used in clinical practice “off-label” since its introduction in 2001 for ...
View Blog: HCV Awareness - http://hcvawareness.blogspot.com/

---

View Post: Gilead Announces Long-Term Data from Two Pivotal Phase III Studies ...
2 Nov 2009
For patients with lamivudine-resistant HBV, adefovir dipivoxil should be used in combination with lamivudine. For all patients, consider modifying treatment in case serum HBV DNA remains above 1000 copies/mL with continued treatment. ...
View Blog: Drugs.com - Clinical Trials - http://www.drugs.com/clinical_trials.html

---

View Post: medicinas.com: Lista de Medicinas Disponibles
18 Nov 2009 by IRTV  
34 ADEFOVIR DIPIVOXIL 10MG 35 adrenaline 1 mg/ml 1 ml ampoule 36 AL HYDROXIDE 300 MG+ MG TRISILICATE 200 MG 37 albendazole 200 mg chewable tablet 38 ALBENDAZOLE 200MG 39 albendazole 400 mg chewable tablet 40 ALBENDAZOLE 400MG ...
View Blog: medicinas.com - http://medicinas-com.blogspot.com/

---